If you’ve turned on a television within the past couple of months you may have noticed a commercial for an injection that claims to dissolve, and thus remove, fat from underneath the chin. This may seem like a hoax to some, but the new drug that is doing just that is Kybella.
Kybella became the first U.S. Food and Drug Administration approved injectable treatment for submental, or under the chin, fat on April 29, 2015. The active ingredient in Kybella is a synthetic form of deoxycholic acid. This naturally occurring acid helps destroy fat cells in the body. Kybella works by targeting those cells, and the body absorbs the destroyed cells, reducing the appearance of your “double chin”.
Ideal candidates have what looks like a pouch of fat underneath their chin. Sometimes this fat is hard to get rid of with exercise and diet alone, and this can be in part due to genetics. People in this situation could be an ideal candidate, but a consultation with a medical provider is necessary to fully confirm that.
Depending on the severity of the “double chin”, a skilled medical provider will determine how many treatments each individual should receive. Patients generally see results after two to four treatments; however, a patient cannot exceed six Kybella treatments. Treatments are spaced no less than a month apart and during each treatment the provider injects the drug multiple times in different spots under the chin. Patients have expressed a slight discomfort upon the injection and soreness afterwards that can be alleviated by icing the area after treatment.
After the ideal amount of treatments has been completed, and the optimal results are achieved, no other treatments should be necessary. This is because the fat is destroyed in that area. As long as patients actively maintain a healthy diet and exercise regularly, the results should be long lasting.
 “FDA Approves Treatment for Fat below the Chin.” FDA Approves Treatment for Fat below the Chin. U.S. Department of Health and Human Services, 29 Apr. 2015. Web. 06 Feb. 2017.